Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.
about
The role of the EP receptors for prostaglandin E2 in skin and skin cancerANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progressionProstanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro.The impact of sphingosine kinase-1 in head and neck cancer.Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis.The tumor promoting activity of the EP4 receptor for prostaglandin E2 in murine skin.Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesisProstaglandin E2 receptor distribution and function in the gastrointestinal tract.Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells.The prostaglandin receptor EP2 activates multiple signaling pathways and beta-arrestin1 complex formation during mouse skin papilloma developmentPhysiology and pathophysiology of prostanoid receptors.Inhibition of prostaglandin E(2) signaling through the EP(1) receptor does not affect prostacyclin production in human endothelial cells.Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.High susceptibility to azoxymethane-induced colorectal carcinogenesis in obese KK-Ay mice.Retinoic acid morpholine amide (RAMA) inhibits expression of Fas ligand through EP1 receptor in colon cancer cells.Implications of chemokine receptors and inflammatory lipids in cancer.The role of COX-2/PGE2 in gossypol-induced apoptosis of colorectal carcinoma cells.The EP4 receptor antagonist, L-161,982, blocks prostaglandin E2-induced signal transduction and cell proliferation in HCA-7 colon cancer cells.Cellular distribution, post-translational modification, and tumorigenic potential of human group III secreted phospholipase A(2).Lubiprostone Increases Small Intestinal Smooth Muscle Contractions Through a Prostaglandin E Receptor 1 (EP1)-mediated PathwayUpregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression.Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer.15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells.Increased severity of renal impairment in nephritic mice lacking the EP1 receptor.Raging the War Against Inflammation With Natural Products
P2860
Q26999707-A389DED9-C151-4DAC-A177-A6599E96D4CFQ28248772-F42D0B50-D921-4542-A6C3-25F2CDCAE814Q33567396-BDC92032-6FED-4BAF-B83E-C1E80EA9A5FBQ33649748-9CA51BFB-62D4-4CDD-A009-5E93D4922A54Q33675073-4ABA4A99-5DE5-4B05-8D48-2D03F48DCDC7Q34619895-3554E6F8-CCAE-4BE8-A968-678644F1B92EQ34662175-E6350E6B-7593-4150-9A36-5EF1DC4276E2Q36611067-63E3D1AD-0C42-401E-9E81-6A6F3320A35BQ36858103-9944B61A-AB46-407C-90BD-B7D0018CD81DQ37329206-368A9CC2-EF65-4C92-9051-1A0BA67EE2CFQ37383933-E88D8D02-78A3-485D-B326-DFEC3430C806Q37399773-CB11F216-7180-4FA3-BC9E-653D0FB88717Q37963769-DCDB42C8-9A4C-4F66-B586-2AA29E1BA8B2Q38340427-14D80E4B-B058-433D-8E97-873899AC30D8Q38849334-5E72F21A-1D5D-4B59-A404-9083E544C33FQ38912259-769AF673-26BD-4E19-91B2-CEF112A24549Q39428320-18C85877-210C-485B-A92F-3E69CC3CCC41Q40107119-7299F344-61C3-4DD0-8F87-7C73EB03C783Q40428682-75E29EE6-AD42-4AB9-918F-A2478F1CA6AEQ41784614-6BDF27CB-B7DD-4189-A838-6DE80B801903Q42483046-28B61A48-D7F4-43EF-ADBA-37F4E41697C9Q46830735-BDDCFD8A-E106-4D5A-8A69-543E5F8B4482Q46958393-9636040A-CC02-4673-BB0F-9C2C2734885FQ53587860-6075CFCC-7FB7-4F2A-9200-75C05D2CD053Q58758818-EE3BB0B7-7766-4CF3-BBA6-EA7CF5DA635E
P2860
Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Prostaglandin E receptor subtype EP
@nl
Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.
@en
type
label
Prostaglandin E receptor subtype EP
@nl
Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.
@en
prefLabel
Prostaglandin E receptor subtype EP
@nl
Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.
@en
P2093
P356
P1433
P1476
Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.
@en
P2093
Keiji Wakabayashi
Kouji Watanabe
Naoaki Uchiya
Shuh Narumiya
Takashi Sugimura
Takayuki Maruyama
Tomohiro Kitamura
Toshihiko Kawamori
P304
P356
10.1093/CARCIN/BGH322
P407
P577
2004-11-25T00:00:00Z